Your browser doesn't support javascript.
loading
Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
Khan, K A; Naylor, A J; Khan, A; Noy, P J; Mambretti, M; Lodhia, P; Athwal, J; Korzystka, A; Buckley, C D; Willcox, B E; Mohammed, F; Bicknell, R.
Afiliação
  • Khan KA; Molecular Angiogenesis Laboratory, Institutes of Biomedical Research and Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Naylor AJ; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Khan A; Molecular Angiogenesis Laboratory, Institutes of Biomedical Research and Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Noy PJ; Molecular Angiogenesis Laboratory, Institutes of Biomedical Research and Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Mambretti M; Molecular Angiogenesis Laboratory, Institutes of Biomedical Research and Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Lodhia P; Molecular Angiogenesis Laboratory, Institutes of Biomedical Research and Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Athwal J; Molecular Angiogenesis Laboratory, Institutes of Biomedical Research and Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Korzystka A; Molecular Angiogenesis Laboratory, Institutes of Biomedical Research and Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Buckley CD; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Willcox BE; Cancer Immunology and Immunotherapy Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Mohammed F; Cancer Immunology and Immunotherapy Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Bicknell R; Molecular Angiogenesis Laboratory, Institutes of Biomedical Research and Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Oncogene ; 36(44): 6097-6108, 2017 11 02.
Article em En | MEDLINE | ID: mdl-28671670

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Glicoproteínas de Membrana / Receptores de Complemento / Antígenos CD / Moléculas de Adesão Celular / Lectinas Tipo C / Antígenos de Neoplasias / Antígenos de Superfície / Neovascularização Patológica Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Glicoproteínas de Membrana / Receptores de Complemento / Antígenos CD / Moléculas de Adesão Celular / Lectinas Tipo C / Antígenos de Neoplasias / Antígenos de Superfície / Neovascularização Patológica Idioma: En Ano de publicação: 2017 Tipo de documento: Article